|
|
|
offer you better
services
|
|
GEMCITABINE HCL
|
|
|
|
We deliver the product Gemcitabine Hcl (in Chemical name)
to several customers in the chemical and lab industry.
Please note the Specification Data
of Gemcitabine HCL in the following
table. |
|
|
|
Gemcitabine HCl is a nucleoside analogue that exhibits antitumor activity.
Gemcitabine
HCl is 2'-deoxy-2', 2'-difluorocytidine monohydrochloride (b-isomer).or
2'-Deoxy-2',2'-Difluorocytidine Hydrochloride.
The empirical formula for gemcitabine
HCl is C9H11F2N3O4
, HCl. It has a Molecular weight of 299.66.
Gemcitabine HCl is a white to off-white
solid. It is soluble in water, slightly soluble in methanol, and
practically insoluble in ethanol and polar organic solvents. The
clinical formulation is supplied in a sterile form for intravenous
use only. Vials contain either 200 mg or 1 g of gemcitabine
HCl (expressed as free base) formulated with mannitol (200 mg or
1 g, respectively) and sodium acetate (12.5 mg or 62.5 mg, respectively)
as a sterile lyophilized powder. Hydrochloric acid and/or sodium
hydroxide may have been added for pH adjustment.
|
|
|
|
S.No. |
TEST |
SPECIFICATIONS |
1 |
DESCRIPTION |
Off
white crystalline powder |
2 |
IDENTIFICATION |
IR. |
3 |
MELTING
RANGE |
286-292<C |
4 |
SPECIFIC
ROTATION (C=1, D2 O) |
Between
+47<
to +52< |
5 |
RELATED
IMPURITIES |
NMT
1.0% |
6 |
ASSAY |
98.0%
- 102.0% w/w |
|
|
|
|
Intermediates of
Gemcitabine HCL |
|
|
|
Ethyl Bromo Difluoro Acetate |
|
|
|
2,2-Dimethoxy
Propane |
|
|
|
Cytosine |
|
|
|
4-Dimethyl
Amino Pyridine |
|
|
|
2,3-Pyridine
Dicarboxylic Acid |
|
|
|
2'-Deoxy-2',2'-difluoro-D-ribofuranose-3,5-dibenzoate-1-methane
sulphonate |
|
|
|
Applications |
|
|
|
Anti
Cancer |
|
|
|
Packing
&loading |
|
|
|
20gram for aluminium foil bag,The
commercial Qty is required |
|
|
|
This data is only for your information purposes and does not imply
guarantee for a certain application.
Please note:
We do not deliver the product Gemcitabine HCl
to private users! |
|
|
|
If you need
an indicative price to your country, please kindly advise the annual
quantity needed, destination port and we will send you our soonest
CNF(Cost + Freight) price. Your indication for a workable price
level will sure speed up our fastest service for you |
|
|
|
We really need to get
feed back from our customers in order to improve our performances.
Any information about quotations from competitors will be welcomed
since we hope to work as a team with you.
Your kind help will be very much appreciated.
Best regards from SHENZHEN
, China
Mr. JEFFERY TSUI
|
|
|
|
|
|
|
|
Material
Safety Data Sheet |
|
|
|
1 |
PRODUCT
& COMPANY IDENTIFICATION: |
Asia
Talent Chemical |
a |
Product
Name |
1-(2-oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-
deoxy-2,2-difluororibose (Gemcitabine HCl);2'-Deoxy-2',2'-Difluoro
Cytidine Hydrochloride;Cytidine, 2'-deoxy-2',2'-difluoro-,
monohydrochloride ;
2'-Deoxy-2',2'-difluorocytidine monohydrochloride (beta-isomer)
Gemcitabine HCl formulation; Gemcitabine; 264368 formulation;
188011 hydrochloride formulation
|
b |
CAS
Number |
[122111-03-9] |
c |
MANUFACTURER |
ASIA
TALENT Chemical |
2 |
PHYSICAL
& CHEMICAL PROPERTIES |
|
a |
PHYSICAL
FORM |
Solid |
b |
APPEARANCE |
Off
white crystalline powder |
c |
ODOR |
Odorless |
d |
CHEMICAL
NAME |
1-(2-oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose |
e |
CHEMICAL
FAMILY |
Cytidine |
f |
MOLECULAR
FORMULA |
C9
H11F2N3O4.HCl |
g |
MOLECULAR
WEIGHT |
299.5 |
h |
MELTING
RANGE |
286-292(C3) |
3 |
FIRST-AID
MEASURES |
|
a |
INHALATION |
Move
affected person to fresh air |
b |
SKIN
CONTACT |
Wash
with plenty of water and then with soap |
c |
EYE
CONTACT |
Wash
with plenty of water for at least 15 minutes In case of irritation
seek medical attention. |
d |
INGESTION |
Rinse
mouth with water.
Give nothing by mouth In case of unconsciousness seek medical
attention. |
4 |
FIRE
FIGHTING MEASURES |
|
a |
SUITABLE
EXTINGUISHING
MEDIA |
Water,
CO2,
powder & Foam extinguishers |
b |
PROTECTIVE
EQUIPMENT FOR FIRE FIGHTERS |
Protective
clothing for chemicals and self |
contained
breathing apparatus. |
5 |
EXPOSURE
CONTROLS / PERSONAL PROTECTION |
|
a |
TECHNICAL
PROTECTIVE MEASURES |
No
special safety measures required |
b |
EXPOSURE
CONTROL LIMITS |
None |
c |
RESPIRATORY
PROTECTION |
In
case of suffocation wear respiratory
protective equipment |
d |
HAND
PROTECTION |
Wear
suitable gloves |
e |
EYE
PROTECTION |
Wear
suitable goggles or face protector |
f |
SKIN
PROTECTION |
Wear
protective clothing |
6 |
STABILITY
& REACTIVITY |
|
a |
STABILITY |
Stable
under normal conditions |
b |
CONDITIONS
TO AVOID |
None |
c |
MATERIALS
TO AVOID |
None |
d |
HAZARDOUS
DECOMPOSION |
Thermal
decomposition or burning may release
carbon dioxide and other toxic gasses |
PRODUCTS |
|
7 |
OTHER
INFORMATION |
This
product should be stored, handled and used in accordance with
good industrial hygiene practice and conformity with any legal
regulation. |
The
information contained herein are based on the present state
of our knowledge and are intended to describe out product from
the point of view of safety requirements.
They should not therefore be constructed as guaranteeing specific
properties |
|
|
|
|
Related Informations
and Materials |
|
|
|
Mechanisms
of the drug resistance of a 2', 2-difluorodeoxycytide (gemcitabine)-resistant
variant of the human lung adenocarcinoma cell line |
|
|
|
Dose
intense triplet chemotherapy with gemcitabine, carboplatin, paclitaxel
with peripheral blood progenitor cell support for six cycles in advanced
epithelial ovarian cancer |
|
|
|
Nuclear
factor Y regulation and promoter transactivation of human ribonucleotide
reductase subunit M2 gene in a Gemcitabine resistant KB clone |
|
|
|
Role
of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation
in radio-enhancement of human head and neck squamous cell carcinomas |
|
|
|
|
|
|
|
If the above information
doesn't cover |
|
|
|
|
|